https://kstockbriefing.com
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Electronics has decided to grant 5,256,775 common shares of treasury stock (valued at approx. KRW 287.55B) to 123,086 eligible employees to foster mutual growth, talent retention, and motivation. 📊 [Key Disclosure Details & Financial Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Execution of Employee…
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary ALTEOGEN will issue and list 146,140 additional common shares following the exercise of stock options by executives and employees. The listing date is set for May 28, 2025. 📊 [Key Disclosure Details & Major Figures Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Additional…
![[Disclosure] Samsung Biologics (207940) – Trading Suspension and Lifting of Suspension (Material Disclosure) / 2025-05-22](https://kstockbriefing.com/wp-content/uploads/2026/07/포맷변환-삼성바이오로직스.jpg)
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has issued a disclosure stating that its stock trading was temporarily suspended at 07:45 KST on May 22, 2025, due to a material disclosure (corporate spin-off decision), and was subsequently lifted at 09:30 KST on the same day following the release of the disclosure….
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has announced a decision to execute a simple spin-off (demerger), separating into a surviving entity focused on its CDMO business and a new entity (Samsung Episholdings Co., Ltd., provisional) dedicated to subsidiary management and investments. The surviving entity will undergo a listing change, while…
Read More “[Disclosure] Samsung Biologics (207940) – Decision on Corporate Spin-off / 2025-05-22” »
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary In conjunction with market measures on the underlying equity, trading of Samsung Biologics’ stock futures and options was temporarily suspended at 07:45 KST on May 22, 2025, and resumed at 09:30 KST on the same day following the lift of the suspension. 📊 [Key Disclosure Details…
![[Disclosure] Hana Micron (067310) – Resolution on Convening General Meeting of Shareholders / 2025-05-21](https://kstockbriefing.com/wp-content/uploads/2026/06/포맷변환-하나마이크론.jpg)
Fact Source: Financial Supervisory Service DART 💡 Executive Summary Hana Micron will hold an extraordinary general meeting of shareholders on July 16, 2025, to vote on approving the corporate split plan, amending the Articles of Incorporation for holding company business purposes, and appointing directors and an auditor. 📊 Key Disclosure Content & Financial Figures Summary…
Fact Source: Financial Supervisory Service DART 💡 Executive Summary Hana Micron has established June 5, 2025, as the record date to determine eligible shareholders for voting at the extraordinary general meeting of shareholders regarding a corporate split. 📊 Key Disclosure Content & Financial Figures Summary 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Extraordinary…
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Aerospace disclosed a corrected decision on its rights offering, updating the calculated offering amount to KRW 2.918T based on the primary issue price set at KRW 684,000 per share. 📊 [Key Disclosure Contents & Major Figures Summary] 1. Purpose of Funds & Offering Size (Post-Amendment…
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Due to the rights offering ex-rights event, the reference price for Hanwha Aerospace common stock effective May 22, 2025, has been set at KRW 837,000. 📊 [Key Disclosure Contents & Major Figures Summary] Reference Price by Share Class 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification…
Read More “[Disclosure] Hanwha Aerospace (012450) – Ex-Rights Reference Price / 2025-05-21” »
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary The primary issue price for Hanwha Aerospace’s rights offering has been set at KRW 684,000 per common share, with the final issue price scheduled to be disclosed on June 27, 2025. 📊 [Key Disclosure Contents & Major Figures Summary] Issue Price Calculation Methods & Schedule 📝…